A Study of LY900014 in Participants With Type 1 Diabetes
Status:
Completed
Trial end date:
2019-08-22
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate the efficacy of the study drug LY900014
compared to insulin lispro, both in combination with insulin glargine or insulin degludec, in
adults with type 1 diabetes (T1D).